Factors associated with a history of treatment interruption among pregnant women living with HIV in Malawi: A cross-sectional study

<h4>Introduction</h4> Long-term care engagement of women on antiretroviral therapy (ART) is essential to effective HIV public health measures. We sought to explore factors associated with a history of HIV treatment interruption among pregnant women living with HIV presenting to an antena...

Full description

Bibliographic Details
Main Authors: Simone A. Sasse, Bryna J. Harrington, Bethany L. DiPrete, Maganizo B. Chagomerana, Laura Limarzi Klyn, Shaphil D. Wallie, Madalitso Maliwichi, Allan N. Jumbe, Irving F. Hoffman, Nora E. Rosenberg, Jennifer H. Tang, Mina C. Hosseinipour, on behalf of the S4 Study
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017884/?tool=EBI
_version_ 1811332359295860736
author Simone A. Sasse
Bryna J. Harrington
Bethany L. DiPrete
Maganizo B. Chagomerana
Laura Limarzi Klyn
Shaphil D. Wallie
Madalitso Maliwichi
Allan N. Jumbe
Irving F. Hoffman
Nora E. Rosenberg
Jennifer H. Tang
Mina C. Hosseinipour
on behalf of the S4 Study
author_facet Simone A. Sasse
Bryna J. Harrington
Bethany L. DiPrete
Maganizo B. Chagomerana
Laura Limarzi Klyn
Shaphil D. Wallie
Madalitso Maliwichi
Allan N. Jumbe
Irving F. Hoffman
Nora E. Rosenberg
Jennifer H. Tang
Mina C. Hosseinipour
on behalf of the S4 Study
author_sort Simone A. Sasse
collection DOAJ
description <h4>Introduction</h4> Long-term care engagement of women on antiretroviral therapy (ART) is essential to effective HIV public health measures. We sought to explore factors associated with a history of HIV treatment interruption among pregnant women living with HIV presenting to an antenatal clinic in Lilongwe, Malawi. <h4>Methods</h4> We performed a cross-sectional study of pregnant women living with HIV who had a history of ART interruption presenting for antenatal care. Women were categorized as either retained in HIV treatment or reinitiating care after loss-to-follow up (LTFU). To understand factors associated with treatment interruption, we surveyed socio-demographic and partner relationship characteristics. Crude and adjusted prevalence ratios (aPR) for factors associated with ART interruption were estimated using modified Poisson regression with robust variance. We additionally present patients’ reasons for ART interruption. <h4>Results</h4> We enrolled 541 pregnant women living with HIV (391 retained and 150 reinitiating). The median age was 30 years (interquartile range (IQR): 25–34). Factors associated with a history of LTFU were age <30 years (aPR 1.46; 95% CI: 1.33–1.63), less than a primary school education (aPR 1.25; CI: 1.08–1.46), initiation of ART during pregnancy or breastfeeding (aPR 1.49, CI: 1.37–1.65), nondisclosure of HIV serostatus to their partner (aPR 1.39, CI: 1.24–1.58), lack of awareness of partner’s HIV status (aPR 1.41, CI: 1.27–1.60), and no contraception use at conception (aPR 1.60, CI 1.40–1.98). Access to care challenges were the most common reasons reported by women for treatment interruption (e.g., relocation, transport costs, or misplacing health documentation). <h4>Conclusions</h4> Interventions that simplify the ART clinic transfer process, facilitate partner disclosure, and provide counseling about the importance of lifelong ART beyond pregnancy and breastfeeding should be further evaluated for improving retention in ART treatment of women living with HIV in Malawi.
first_indexed 2024-04-13T16:35:35Z
format Article
id doaj.art-d05d809b977b43ffba7d3e4c7729dfd0
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T16:35:35Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d05d809b977b43ffba7d3e4c7729dfd02022-12-22T02:39:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01174Factors associated with a history of treatment interruption among pregnant women living with HIV in Malawi: A cross-sectional studySimone A. SasseBryna J. HarringtonBethany L. DiPreteMaganizo B. ChagomeranaLaura Limarzi KlynShaphil D. WallieMadalitso MaliwichiAllan N. JumbeIrving F. HoffmanNora E. RosenbergJennifer H. TangMina C. Hosseinipouron behalf of the S4 Study<h4>Introduction</h4> Long-term care engagement of women on antiretroviral therapy (ART) is essential to effective HIV public health measures. We sought to explore factors associated with a history of HIV treatment interruption among pregnant women living with HIV presenting to an antenatal clinic in Lilongwe, Malawi. <h4>Methods</h4> We performed a cross-sectional study of pregnant women living with HIV who had a history of ART interruption presenting for antenatal care. Women were categorized as either retained in HIV treatment or reinitiating care after loss-to-follow up (LTFU). To understand factors associated with treatment interruption, we surveyed socio-demographic and partner relationship characteristics. Crude and adjusted prevalence ratios (aPR) for factors associated with ART interruption were estimated using modified Poisson regression with robust variance. We additionally present patients’ reasons for ART interruption. <h4>Results</h4> We enrolled 541 pregnant women living with HIV (391 retained and 150 reinitiating). The median age was 30 years (interquartile range (IQR): 25–34). Factors associated with a history of LTFU were age <30 years (aPR 1.46; 95% CI: 1.33–1.63), less than a primary school education (aPR 1.25; CI: 1.08–1.46), initiation of ART during pregnancy or breastfeeding (aPR 1.49, CI: 1.37–1.65), nondisclosure of HIV serostatus to their partner (aPR 1.39, CI: 1.24–1.58), lack of awareness of partner’s HIV status (aPR 1.41, CI: 1.27–1.60), and no contraception use at conception (aPR 1.60, CI 1.40–1.98). Access to care challenges were the most common reasons reported by women for treatment interruption (e.g., relocation, transport costs, or misplacing health documentation). <h4>Conclusions</h4> Interventions that simplify the ART clinic transfer process, facilitate partner disclosure, and provide counseling about the importance of lifelong ART beyond pregnancy and breastfeeding should be further evaluated for improving retention in ART treatment of women living with HIV in Malawi.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017884/?tool=EBI
spellingShingle Simone A. Sasse
Bryna J. Harrington
Bethany L. DiPrete
Maganizo B. Chagomerana
Laura Limarzi Klyn
Shaphil D. Wallie
Madalitso Maliwichi
Allan N. Jumbe
Irving F. Hoffman
Nora E. Rosenberg
Jennifer H. Tang
Mina C. Hosseinipour
on behalf of the S4 Study
Factors associated with a history of treatment interruption among pregnant women living with HIV in Malawi: A cross-sectional study
PLoS ONE
title Factors associated with a history of treatment interruption among pregnant women living with HIV in Malawi: A cross-sectional study
title_full Factors associated with a history of treatment interruption among pregnant women living with HIV in Malawi: A cross-sectional study
title_fullStr Factors associated with a history of treatment interruption among pregnant women living with HIV in Malawi: A cross-sectional study
title_full_unstemmed Factors associated with a history of treatment interruption among pregnant women living with HIV in Malawi: A cross-sectional study
title_short Factors associated with a history of treatment interruption among pregnant women living with HIV in Malawi: A cross-sectional study
title_sort factors associated with a history of treatment interruption among pregnant women living with hiv in malawi a cross sectional study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017884/?tool=EBI
work_keys_str_mv AT simoneasasse factorsassociatedwithahistoryoftreatmentinterruptionamongpregnantwomenlivingwithhivinmalawiacrosssectionalstudy
AT brynajharrington factorsassociatedwithahistoryoftreatmentinterruptionamongpregnantwomenlivingwithhivinmalawiacrosssectionalstudy
AT bethanyldiprete factorsassociatedwithahistoryoftreatmentinterruptionamongpregnantwomenlivingwithhivinmalawiacrosssectionalstudy
AT maganizobchagomerana factorsassociatedwithahistoryoftreatmentinterruptionamongpregnantwomenlivingwithhivinmalawiacrosssectionalstudy
AT lauralimarziklyn factorsassociatedwithahistoryoftreatmentinterruptionamongpregnantwomenlivingwithhivinmalawiacrosssectionalstudy
AT shaphildwallie factorsassociatedwithahistoryoftreatmentinterruptionamongpregnantwomenlivingwithhivinmalawiacrosssectionalstudy
AT madalitsomaliwichi factorsassociatedwithahistoryoftreatmentinterruptionamongpregnantwomenlivingwithhivinmalawiacrosssectionalstudy
AT allannjumbe factorsassociatedwithahistoryoftreatmentinterruptionamongpregnantwomenlivingwithhivinmalawiacrosssectionalstudy
AT irvingfhoffman factorsassociatedwithahistoryoftreatmentinterruptionamongpregnantwomenlivingwithhivinmalawiacrosssectionalstudy
AT noraerosenberg factorsassociatedwithahistoryoftreatmentinterruptionamongpregnantwomenlivingwithhivinmalawiacrosssectionalstudy
AT jenniferhtang factorsassociatedwithahistoryoftreatmentinterruptionamongpregnantwomenlivingwithhivinmalawiacrosssectionalstudy
AT minachosseinipour factorsassociatedwithahistoryoftreatmentinterruptionamongpregnantwomenlivingwithhivinmalawiacrosssectionalstudy
AT onbehalfofthes4study factorsassociatedwithahistoryoftreatmentinterruptionamongpregnantwomenlivingwithhivinmalawiacrosssectionalstudy